Gender, age, and CTV coverage (HR 0.15, p = 0.08; HR 0.93, p = 0.10; HR 0.82, p = 0.10) showed a trend to correlation indicating a lower chance of change in systemic therapy for older male patients with a higher V95% of the CTV.
← all excerpts
Time to Next Treatment Following Sub-Ablative Progression Directed Radiation Therapy for Oligoprogressive Non-Small-Cell Lung Cancer.
1
—
—